DNA demethylating therapy reverts mesenchymal stromal cells derived from high risk myelodysplastic patients to a normal phenotype. (22nd April 2016)

Record Type:: Journal Article
Title:: DNA demethylating therapy reverts mesenchymal stromal cells derived from high risk myelodysplastic patients to a normal phenotype. (22nd April 2016)
Main Title:: DNA demethylating therapy reverts mesenchymal stromal cells derived from high risk myelodysplastic patients to a normal phenotype
Authors:: Maurizi, Giulia
Mattiucci, Domenico
Mariani, Marianna
Ciarlantini, Marco
Traini, Sabrina
Mancini, Stefania
Olivieri, Attilio
Leoni, Pietro
Poloni, Antonella
Abstract:
Is Part Of:: British journal of haematology. Volume 177:Number 5(2017)
Journal:: British journal of haematology
Issue:: Volume 177:Number 5(2017)
Issue Display:: Volume 177, Issue 5 (2017)
Year:: 2017
Volume:: 177
Issue:: 5
Issue Sort Value:: 2017-0177-0005-0000
Page Start:: 818
Page End:: 822
Publication Date:: 2016-04-22
Subjects:: myelodysplastic syndrome -- mesenchymal stromal cell -- mesenchymal stem cell -- azacitidine -- demethylating agents
Hematology -- Periodicals
Blood -- Diseases -- Periodicals
616.15
Journal URLs:: http://www.blacksci.co.uk/%7Ecgilib/jnlpage.bin?Journal=bjh&File=bjh&Page=aims ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2141 ↗
http://onlinelibrary.wiley.com/ ↗
DOI:: 10.1111/bjh.14115 ↗
Languages:: English
ISSNs:: 0007-1048
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 2309.000000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 1907.xml